Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders??? Equity (Deficit)

v3.23.1
Consolidated Statements of Changes in Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated other comprehensive loss
Accumulated Deficit
Balance (in shares) at Dec. 31, 2019   221,829,175      
Balance at Dec. 31, 2019 $ (113,120) $ 22 $ 428,328 $ 41 $ (541,511)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (121,652)       (121,652)
Stock-based compensation 3,154   3,154    
Exercise of stock options (in shares)   108,456      
Exercise of stock options 409   409    
Advances to stock option holders (18)   (18)    
Other comprehensive loss 93     93  
Parent Company contributions (in shares)   44,681,954      
Parent Company contributions 150,000 $ 5 149,995    
Parent Company distributions (118,488)   (118,488)    
Balance (in shares) at Dec. 31, 2020   266,619,585      
Balance at Dec. 31, 2020 (199,622) $ 27 463,380 134 (663,163)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (157,291)       (157,291)
Stock-based compensation 10,621   10,621    
Exercise of stock options (in shares)   963,790      
Exercise of stock options 2,807   2,807    
Advances to stock option holders 18   18    
Other comprehensive loss (137)     (137)  
Parent Company contributions (in shares)   35,737,509      
Parent Company contributions 169,140 $ 3 169,137    
Conversion of long-term debt due to Parent Company to Parent Company non-cash contributions 235,108   235,108    
Reverse recapitalization, net of transaction costs (in shares)   31,599,030      
Reverse recapitalization, net of transaction costs 152,326 $ 4 152,322    
Balance (in shares) at Dec. 31, 2021   334,919,914      
Balance at Dec. 31, 2021 212,970 $ 34 1,033,393 (3) (820,454)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (191,158)       (191,158)
Stock-based compensation 18,636   18,636    
Exercise of stock options (in shares)   402,185      
Exercise of stock options 1,480   1,480    
Issuance of common stock pursuant to stock-based awards (in shares)   5,406      
Other comprehensive loss $ (116)     (116)  
Issuance of common stock due to convertible note conversion (in shares) 2,382,497 2,382,498      
Issuance of common stock due to convertible note conversion $ 6,608   6,608    
Balance (in shares) at Dec. 31, 2022   337,710,003      
Balance at Dec. 31, 2022 $ 48,420 $ 34 $ 1,060,117 $ (119) $ (1,011,612)